Chroma Medicine launches with $125M in financing

By The Science Advisory Board staff writers

November 17, 2021 -- Genomic medicine company Chroma Medicine has launched with $125 million in financing.

The funds will be used to advance programmable epigenetic editors that harness innate mechanisms to precisely control gene expression without changing or cutting the underlying DNA sequence, according to the company.

Copyright © 2021

Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter